IBM shares slid as much as 4% in extended trading on Monday after the company trimmed its 2022 cash forecast. It still beat on the top and bottom lines.
Here’s how the company did:
- Earnings: $2.31 per share, adjusted, vs. $2.27 per share as expected by analysts, according to Refinitiv.
- Revenue: $15.54 billion, vs. $15.18 billion as expected by analysts, according to Refinitiv.
IBM’s revenue rose 9% year over year in the quarter, according to a statement. Income from continuing operations increased to $1.47 billion from $810 million in the year-ago quarter. IBM spun off its managed infrastructure services business into publicly traded Kyndryl in November, and sales to Kyndryl boosted IBM’s revenue.
Management called for $10 billion in free cash flow for all of 2022, down from the range of $10 billion to $10.5 billion that it provided in April. Executives reiterated their plan for constant-currency revenue growth at the high end of their mid-single-digit model for the year.
Currency negatively impacted reported revenue by over 6% of growth, or $900 million, which was $200 more than spot rates had indicated three months ago, Jim Kavanaugh, IBM’s finance chief, said on a conference call with analysts.
IBM reported $6.17 billion in software revenue in the second quarter, up 6% but below the $6.3 billion consensus among analysts polled by StreetAccount.
The company’s consulting division generated $4.81 billion in revenue, jumping nearly 10% and surpassing the StreetAccount consensus of $4.67 billion.
IBM’s infrastructure unit, which includes mainframe computers, contributed $4.24 billion in revenue, up almost 19% and well above the $3.79 billion StreetAccount consensus. On May 31, IBM started selling its latest mainframe, the z16. Each mainframe cycle generally brings revenue growth at the beginning as customers upgrade, followed by a decline. Sales of z Systems products rose 69%, compared with a decline of 19% in the first quarter.
Also in the quarter, IBM announced a plan to acquire cybersecurity startup Randori, and Francisco Partners closed its acquisition IBM’s Watson health care data and analytics assets in a deal reportedly worth more than $1 billion.
IBM’s gross margin narrowed to 53.4% from 55.2% in the year-ago quarter. The company said the competitive labor market impacted results in its consulting arm, continuing a trend it saw earlier in the year.
Prior to the after-hours move, IBM shares were up 3% so far this year, while the S&P 500 index tumbled about 20%.
This story is developing. Please check back for updates.
WATCH: We’re not seeing a slowdown in the B2B space, says IBM CEO